Testing effectiveness (Phase 2)Ended earlyNCT02781506
What this trial is testing
Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma
Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
University of Texas Southwestern Medical Center 7